Pregled bibliografske jedinice broj: 260930
Genotoxicity of irinotecan in human lymphocytes assessed using the cytokinesis-block micronucleus assay in vitro
Genotoxicity of irinotecan in human lymphocytes assessed using the cytokinesis-block micronucleus assay in vitro // PROGRAMME AND ABSTRACTS ; From Genes to Molecular Epidemiology, 36th Annual Meeting of the European Environmental Mutagen Society / Šram, Radim J. (ur.).
Prag: EEMS, 2006. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 260930 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Genotoxicity of irinotecan in human lymphocytes assessed using the cytokinesis-block micronucleus assay in vitro
Autori
Kopjar, Nevenka ; Ramić, Snježana ; Milić, Mirta ; Pavlica, Vesna
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
PROGRAMME AND ABSTRACTS ; From Genes to Molecular Epidemiology, 36th Annual Meeting of the European Environmental Mutagen Society
/ Šram, Radim J. - Prag : EEMS, 2006
Skup
36th Annual Meeting of the European Environmental Mutagen Society
Mjesto i datum
Prag, Češka Republika, 02.07.2006. - 06.07.2006
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
irinotecan; human lymphocytes; in vitro; micronucleus assay
Sažetak
Irinotecan is a promising antitumor agent, mostly used in the treatment of metastatic colorectal cancer. In spite of widespread use, its cytogenetic effects were not extensively studied. The objective of present study was to evaluate the level of genetic changes in human lymphocytes exposed to two therapeutic doses (180 mg/m2 and 350 mg/m2) of irinotecan in vitro. The DNA damage was estimated using cytokinesis-block micronucleus (CBMN) assay. The frequencies of micronuclei (MN), nuclear buds, nucleoplasmic bridges as well as apoptotic morphological changes in fixed cells were studied simultaneously. Moreover, nuclear division index both in treated and control cells was estimated. The results show that irinotecan induced marked genetic changes, especially increased incidence of MN and nuclear buds as compared to untreated control. Genotoxic effects of irinotecan on lymphocytes were dose-dependent. Both concentrations caused a significant increase in the fraction of apoptotic cells. Irinotecan also induced cytotoxicity as measured by nuclear division index. Based on the results obtained we can conclude that both therapeutic concentrations of irinotecan are geno/cytotoxic to human non-target cells. Our results also point to the importance of biomarker studies in non-target cells of cancer patients after successful chemotherapy since they could be a good predictive factor to detect subpopulations of patients with genome instability.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Farmacija
POVEZANOST RADA
Projekti:
0022019
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb,
Klinika za tumore